Search

everythinglearnresearchcommunity

for

Search:↓

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

The study suggests that acne keloidalis nuchae is linked to conditions like pseudofolliculitis barbae, scalp infections, metabolic syndrome, and is more common in males with an average onset age of 25.4 years.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

A woman showed neurological symptoms from psittacosis linked to bird exposure, improving after antibiotic treatment.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Inner city teens had high retention rates for the contraceptive implant, especially those with a history of abortion.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.